Definitive Contract 75F40124C00087
Award Date
8/15/24
Potential Completion Date
3/7/25
Potential Value
$243K
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
PSC Category
B529 - Special Studies/Analysis- Scientific Data
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10032, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,050,310 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division. The contract, which has no set-aside designation, is for a project titled "CDER NEURODEVELOPMENTAL AND MENTAL HEALTH OUTCOMES IN PRETERM INFANTS: EFFECTS OF EXP" with a period of performance ending on March 7, 2025. The contract was awarded under a Broad Agency...
The U.S. Food and Drug Administration (FDA) awarded a time and materials delivery order contract worth $1,974,744.12 to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, to provide support for the FDA's Community Engagement and Development Initiative. This contract, which does not have a set-aside designation, will run through September 29, 2026. As a leading research institution, Columbia University has extensive expertise in biomedical...
The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, was awarded a $3,567,988.74 time and materials delivery order contract by the Food and Drug Administration (FDA) to provide support for the FDA's Community Engagement and Development Initiative. This contract, which does not have a set-aside designation, will run through March 7, 2025. As a leading research institution, Columbia University has extensive experience conducting biomedical...
The Department of Health and Human Services Food and Drug Administration awarded a $1.1 million delivery order to The Trustees of Columbia University in New York, doing business as Columbia University's Health Sciences Division. The order is for the Biosafety Effectiveness and Safety Community Engagement and Development Initiative, a one-year, time and materials contract to support the FDA's efforts to engage communities and develop understanding of biologics effectiveness and safety. As the...
This is a $1,721,851 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division. The contract, which does not have a set-aside designation, is for a study examining the effects of postnatal management approaches, including non-pharmacological and opioid replacement pharmacotherapy, as well as the timing and duration of gestational opioid exposure, on...
This is a federal contract award from the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division. The $94,591.05 delivery order is for biomedical research services and does not have a set-aside designation. The contract is a type of Indefinite Delivery Vehicle (IDV) that allows the CDC to continuously...
The Department of Health and Human Services Food and Drug Administration awarded a $1,916,514.00 definitive contract to The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, to conduct research on neurodevelopmental outcomes in infants receiving opioid-replacement pharmacotherapy for neonatal opioid withdrawal syndrome (NOWS). The contract has a completion date of June 30, 2024 and does not utilize a set-aside designation. As part of this...
This federal contract award to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, is for a Pediatric COVID-19 Vaccination Randomized Controlled Trial (RCT). The award, valued at $730,877, was made by the Centers for Disease Control and Prevention (CDC) under the Clinical Immunization Safety Assessment (CISA) contract vehicle. The contract has a period of performance ending on December 28, 2025. There is no set-aside designation for this...
This federal contract award was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency under the Department of Health and Human Services. The $288,983.05 delivery order contract was awarded to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, to provide services related to protocol review, protocol development, and consultation in the female topic area. The contract does not have a set-aside...
This is a definitive federal contract awarded by the Department of Health and Human Services to The Trustees of Columbia University in the City of New York, operating through its Sponsored Projects Administration Division. The contract is for other professional services and has a ceiling value of $4,162,930.00. There is no set-aside designation for this award. The contract demonstrates Columbia University's significant role in conducting research and providing services to the federal government....